Results 221 to 230 of about 939,403 (293)
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T cell therapy in patients with progressive systemic sclerosis (SSc). Methods Patients with progressive SSc received CD19 chimeric antigen receptor (CAR)‐T cell therapy and were observed longitudinally for safety, clinical efficacy,
Chenhan Jia +16 more
wiley +1 more source
Objective Tissue‐specific biomarkers that are reliable and associated with clinical manifestations of idiopathic inflammatory myopathy (IIM) are lacking. The blood circulation in individuals serves as a central conduit, allowing communication between tissues and facilitating clearance and recycling of tissue‐derived proteins.
Yue‐Bei Luo +23 more
wiley +1 more source
Systemic Inflammation and the Persistence of Vaccine-Induced Hepatitis B Immunity in Healthcare Workers. [PDF]
Çoruh Akyol B +3 more
europepmc +1 more source
Cerebral Venous Sinus Thrombosis With Bilateral Blindness in Systemic Lupus Erythematosus: A Case Report. [PDF]
Uddin MG +5 more
europepmc +1 more source
Clinical Experience With Eliglustat in Children With Gaucher Disease Type 1
American Journal of Medical Genetics Part A, EarlyView.
Erika R. Vucko +6 more
wiley +1 more source
Clinical pharmacist-guided management of heparin-induced thrombocytopenia with thrombosis after hip hemiarthroplasty: a case report. [PDF]
Yin Q, Han L, Bian Y, Song Y, Huang Y.
europepmc +1 more source
Wang L, Wang J, Li J, Coller BS. A monoclonal antibody to platelet αIIbβ3 that inhibits protein disulfide isomerase binding and platelet aggregation. Blood Adv. 2026;10(9):3172-3185. [PDF]
europepmc +1 more source
Soluble CLEC-2 as an Emerging Biomarker of In Vivo Platelet Activation. [PDF]
Suzuki-Inoue K +4 more
europepmc +1 more source

